Literature DB >> 22374658

[Living wills under close scrutiny: Medical consultation is indispensable].

M Schöffner1, K W Schmidt, U Benzenhöfer, S Sahm.   

Abstract

Since September 2009 the handling of living wills has been regulated by law. Even though a medical consultation is not imperative for the drawing up of a living will, first surveys have shown that medical information about clinical pictures and treatment options lead to an important specification of living wills. For the first time in Germany, a questionnaire has been developed to investigate the impact of medical consultations on the content of living wills. It revealed that nearly all the people surveyed who had already drawn up a living will wished to change the content of their completed will after attending the seminar because the previous version was no longer in accordance with their wishes. In the light of the frequent difficulties in hospitals concerning how to apply a living will to an actual clinical situation, we believe structured medical consultations to be indispensable. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2012        PMID: 22374658     DOI: 10.1055/s-0031-1298998

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  3 in total

1.  Advance Directives and Powers of Attorney in Intensive Care Patients.

Authors:  Geraldine de Heer; Bernd Saugel; Barbara Sensen; Charlotte Rübsteck; Hans O Pinnschmidt; Stefan Kluge
Journal:  Dtsch Arztebl Int       Date:  2017-06-05       Impact factor: 5.594

2.  [Inadequate ICU-admissions : A 12-month prospective cohort study at a German University Hospital].

Authors:  K Bangert; J Borch; S Ferahli; S A Braune; G de Heer; S Kluge
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-09-04       Impact factor: 0.840

3.  Intricate decision making: ambivalences and barriers when fulfilling an advance directive.

Authors:  Lars Schröder; Gerhard Hommel; Stephan Sahm
Journal:  Patient Prefer Adherence       Date:  2016-08-16       Impact factor: 2.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.